Heiko Trautmann

3.0k total citations
15 papers, 716 citations indexed

About

Heiko Trautmann is a scholar working on Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Heiko Trautmann has authored 15 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Pathology and Forensic Medicine and 8 papers in Hematology. Recurrent topics in Heiko Trautmann's work include Acute Lymphoblastic Leukemia research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Heiko Trautmann is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Heiko Trautmann collaborates with scholars based in Germany, Italy and Czechia. Heiko Trautmann's co-authors include Monika Brüggemann, Nicola Gökbuget, Michael Kneba, Dieter Hoelzer, C. R. Bartram, Harald Rieder, Christiane Pott, Rainer Fietkau, Hubert Serve and Renate Arnold and has published in prestigious journals such as Blood, Oncogene and Leukemia.

In The Last Decade

Heiko Trautmann

13 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiko Trautmann Germany 6 413 400 244 196 127 15 716
Silja Röttgers Germany 13 453 1.1× 463 1.2× 192 0.8× 71 0.4× 81 0.6× 14 778
SA Shurtleff United States 9 311 0.8× 377 0.9× 144 0.6× 150 0.8× 117 0.9× 9 706
R Panzer-Grümayer Austria 11 503 1.2× 373 0.9× 100 0.4× 79 0.4× 71 0.6× 13 753
L Elia Italy 13 461 1.1× 507 1.3× 109 0.4× 62 0.3× 114 0.9× 29 691
Markéta Kalinová Czechia 13 296 0.7× 232 0.6× 121 0.5× 87 0.4× 43 0.3× 38 581
S Raimondi United States 11 437 1.1× 707 1.8× 137 0.6× 143 0.7× 137 1.1× 19 1.1k
TE Hansen-Hagge Germany 11 393 1.0× 346 0.9× 213 0.9× 103 0.5× 102 0.8× 15 695
Sandra Weißmann Germany 10 252 0.6× 525 1.3× 91 0.4× 159 0.8× 317 2.5× 28 861
Hendrik Wessels Germany 5 387 0.9× 275 0.7× 401 1.6× 149 0.8× 51 0.4× 14 644
CR Bartram Germany 5 400 1.0× 401 1.0× 79 0.3× 79 0.4× 140 1.1× 6 613

Countries citing papers authored by Heiko Trautmann

Since Specialization
Citations

This map shows the geographic impact of Heiko Trautmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Trautmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Trautmann more than expected).

Fields of papers citing papers by Heiko Trautmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko Trautmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Trautmann. The network helps show where Heiko Trautmann may publish in the future.

Co-authorship network of co-authors of Heiko Trautmann

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko Trautmann. A scholar is included among the top collaborators of Heiko Trautmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko Trautmann. Heiko Trautmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kotrová, Michaela, Heiko Trautmann, Nael Alakel, et al.. (2022). Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods. Blood Advances. 6(10). 3006–3010. 22 indexed citations
2.
Bastian, Lorenz, Sonja Hänzelmann, Martín Neumann, et al.. (2020). Molecular Subtypes with Distinct Clinical Phenotypes and Actionable Targets in Adult B Cell Precursor ALL Treatment According to GMALL Protocols. Blood. 136(Supplement 1). 11–12. 1 indexed citations
3.
Chitadze, Guranda, Anna Stengel, Heiko Trautmann, et al.. (2019). S129 TP53 SOMATIC MUTATIONS AS PRE‐LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA. HemaSphere. 3(S1). 16–17. 1 indexed citations
4.
Szczepanowski, Monika, Johanna Richter, Matthias Ritgen, et al.. (2018). CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial. Blood. 132(Supplement 1). 1409–1409. 3 indexed citations
5.
Kotrová, Michaela, Henrik Knecht, Dietrich Herrmann, et al.. (2018). The IG/TR Next Generation Marker Screening Developed within Euroclonality-NGS Consortium Is Successful in 94% of Acute Lymphoblastic Leukemia Samples. Blood. 132(Supplement 1). 2830–2830. 2 indexed citations
6.
Nagel, Inga, Marius Bartels, Johannes Duell, et al.. (2017). Hematopoietic stem cell involvement in BCR-ABL1–positive ALL as a potential mechanism of resistance to blinatumomab therapy. Blood. 130(18). 2027–2031. 63 indexed citations
7.
Loeffler, Markus, Markus Kreuz, Andrea Haake, et al.. (2014). Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia. 29(2). 456–463. 42 indexed citations
8.
Ladetto, Marco, Monika Brüggemann, Luigia Monitillo, et al.. (2013). Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 28(6). 1299–1307. 218 indexed citations
9.
Pott, Christiane, Luigia Monitillo, Elisa Genuardi, et al.. (2013). A Comparative Analysis Of Next-Generation Sequencing and Real-Time Quantitative PCR For Minimal Residual Disease Detection In Follicular Lymphomas. Blood. 122(21). 4293–4293. 4 indexed citations
10.
11.
Bartels, Marius, Inga Nagel, Heiko Trautmann, et al.. (2013). Subclonal IKZF1 Deletions Indicate a Multiclonal Evolution In BCR-ABL1-Positive B-Cell Precursor ALL. Blood. 122(21). 1327–1327. 1 indexed citations
12.
13.
Gökbuget, Nicola, Michael Kneba, Thorsten Raff, et al.. (2012). Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood. 120(9). 1868–1876. 329 indexed citations
14.
Trautmann, Heiko, Anastasia Hadzidimitriou, Nikos Darzentas, et al.. (2009). Evidence for Antigen-Driven Development of Molecularly Classified Burkitt Lymphomas.. Blood. 114(22). 317–317. 2 indexed citations
15.
Starczynowski, Daniel T., Heiko Trautmann, Christiane Pott, et al.. (2006). Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity. Oncogene. 26(19). 2685–2694. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silja Röttgers Breakdown of academic impact, for papers by SA Shurtleff Breakdown of academic impact, for papers by R Panzer-Grümayer Breakdown of academic impact, for papers by L Elia Breakdown of academic impact, for papers by Markéta Kalinová Breakdown of academic impact, for papers by S Raimondi Breakdown of academic impact, for papers by TE Hansen-Hagge Breakdown of academic impact, for papers by Sandra Weißmann Breakdown of academic impact, for papers by Hendrik Wessels Breakdown of academic impact, for papers by CR Bartram
Rankless by CCL
2026